Risk of Cardiovascular Events Associated with Chronic Obstructive Pulmonary Disease and/or Metabolic Syndrome: A Large-Scale Nationwide Population-Based Cohort Study

References

• Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018;12:1753465817750524. doi:10.1177/1753465817750524
   Web of Science ®Google Scholar
• Martinez CH, Han MK. Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes. Med Clin North Am. 2012;96(4):713–727. doi:10.1016/j.mcna.2012.02.007
   PubMed Web of Science ®Google Scholar
• Naik D, Joshi A, Paul TV, Thomas N. Chronic obstructive pulmonary disease and the metabolic syndrome: consequences of a dual threat. Indian J Endocrinol Metab. 2014;18(5):608–616. doi:10.4103/2230-8210.139212
   PubMedGoogle Scholar
• Gershon AS, Thiruchelvam D, Aaron S, et al. Socioeconomic status (SES) and 30-day hospital readmissions for chronic obstructive pulmonary (COPD) disease: a population-based cohort study. PLoS One. 2019;14(5):e0216741. doi:10.1371/journal.pone.0216741
   PubMed Web of Science ®Google Scholar
• Shnoda M, Gajjar K, Ivanova V, Iva Nova V. COPD and cardiovascular disease: a review of association, interrelationship, and basic principles for integrated management. Crit Care Nurs Q. 2021;44(1):91–102. doi:10.1097/CNQ.0000000000000342
   PubMed Web of Science ®Google Scholar
• Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA. Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors. Diabetes Metab Res Rev. 2022;38(3):e3502. doi:10.1002/dmrr.3502
   PubMed Web of Science ®Google Scholar
• Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, Toledo E, Moreno-Iribas C. RIVANA Study Investigators. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 2020;19(1):195. doi:10.1186/s12933-020-01166-6
   PubMed Web of Science ®Google Scholar
• Chan SMH, Selemidis S, Bozinovski S, Vlahos R. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies. Pharmacol Ther. 2019;198:160–188.
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest. 2009;136(4):1039–1046. doi:10.1378/chest.09-0393
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. doi:10.1183/09031936.00128008
   PubMed Web of Science ®Google Scholar
• Bernardo I, Bozinovski S, Vlahos R. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities. Pharmacol Ther. 2015;155:60–79.
   PubMed Web of Science ®Google Scholar
• Ropcke S, Holz O, Lauer G, et al. Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum. PLoS One. 2012;7(10):e46207. doi:10.1371/journal.pone.0046207
   PubMed Web of Science ®Google Scholar
• de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;582(1):97–105. doi:10.1016/j.febslet.2007.11.057
   PubMed Web of Science ®Google Scholar
• Díez-Manglano J, Barquero-Romero J, Almagro P, et al. COPD patients with and without metabolic syndrome: clinical and functional differences. Intern Emerg Med. 2014;9(4):419–425. doi:10.1007/s11739-013-0945-7
   PubMed Web of Science ®Google Scholar
• Kang HR, Hong SH, Ha SY, Kim TB, Lee EK. Differences in the risk of mood disorders in patients with asthma-COPD overlap and in patients with COPD alone: a nationwide population-based retrospective cohort study in Korea. Respir Res. 2019;20(1):80. doi:10.1186/s12931-019-1039-5
   PubMed Web of Science ®Google Scholar
• Kim BY, Kang SM, Kang JH, et al. 2020 Korean society for the study of obesity guidelines for the management of obesity in Korea. J Obes Metab Syndr. 2021;30:81–92. doi:10.7570/jomes21022
   PubMed Web of Science ®Google Scholar
• Kim SY, Go TH, Lee JH, et al. Differential association of metabolic syndrome and low-density lipoprotein cholesterol with incident cardiovascular disease according to sex among Koreans: a national population-based study. Eur J Prev Cardiol. 2022;28(18):2021–2029. doi:10.1093/eurjpc/zwaa114
   PubMed Web of Science ®Google Scholar
• Liu J, Grundy SM, Wang W, et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J. 2007;153(4):552–558. doi:10.1016/j.ahj.2007.01.003
   PubMed Web of Science ®Google Scholar
• Ramalho SHR, Shah AM. Lung function and cardiovascular disease: a link. Trends Cardiovasc Med. 2021;31(2):93–98. doi:10.1016/j.tcm.2019.12.009
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514–1519. doi:10.1161/01.CIR.0000056767.69054.B3
   PubMed Web of Science ®Google Scholar
• Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16(1):63–70. doi:10.1016/j.annepidem.2005.04.008
   PubMed Web of Science ®Google Scholar
• Wolf PA, Lewis A. Conner Lecture. Contributions of epidemiology to the prevention of stroke. Circulation. 1993;88(5):2471–2478. doi:10.1161/01.CIR.88.5.2471
   PubMed Web of Science ®Google Scholar
• Kannel WB, Wolf PA, Garrison RJ. Monograph Section 34: Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study, 30-Year Follow-Up. Springfield, MA: National Technical Information Service; 1987:1–459.
   Google Scholar
• Devers MC, Campbell S, Simmons D. Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease. BMJ Open Diabetes Res Care. 2016;4(1):e000195. doi:10.1136/bmjdrc-2016-000195
   PubMed Web of Science ®Google Scholar
• Park BH, Park MS, Chang J, et al. Chronic obstructive pulmonary disease and metabolic syndrome: a nationwide survey in Korea. Int J Tuberc Lung Dis. 2012;16(5):694–700. doi:10.5588/ijtld.11.0180
   PubMed Web of Science ®Google Scholar
• Beijers RJ, van de Bool C, van den Borst B, Franssen FME, Wouters EFM, Schols AM. Normal weight but low muscle mass and abdominally obese: implications for the cardiometabolic risk profile in chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2017;18(6):533–538. doi:10.1016/j.jamda.2016.12.081
   PubMed Web of Science ®Google Scholar
• Park JH, Lee JK, Heo EY, Kim DK, Chung HS. The effect of obesity on patients with mild chronic obstructive pulmonary disease: results from KNHANES 2010 to 2012. Int J Chron Obstruct Pulmon Dis. 2017;12:757–763. doi:10.2147/COPD.S126192
   PubMed Web of Science ®Google Scholar
• Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA. 2015;313(19):1973–1974. doi:10.1001/jama.2015.4260
   PubMed Web of Science ®Google Scholar
• Tran BT, Jeong BY, Oh JK. The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean national health and nutrition examination survey 2008–2013. BMC Public Health. 2017;17(1):71. doi:10.1186/s12889-016-3936-6
   PubMed Web of Science ®Google Scholar
• Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458. doi:10.1016/S2213-2600(21)00511-7
   PubMed Web of Science ®Google Scholar
• Hwang YI, Park YB, Yoo KH. Recent trends in the prevalence of chronic obstructive pulmonary disease in Korea. Tuberc Respir Dis. 2017;80(3):226–229. doi:10.4046/trd.2017.80.3.226
   PubMed Web of Science ®Google Scholar